<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02961842</url>
  </required_header>
  <id_info>
    <org_study_id>R/16.09.64</org_study_id>
    <nct_id>NCT02961842</nct_id>
  </id_info>
  <brief_title>Combined Colloid Preload And Crystalloid Coload Versus Crystalloid Coload During Spinal Anesthesia for Cesarean Delivery</brief_title>
  <official_title>Combined Colloid Preload And Crystalloid Coload Versus Crystalloid Coload During Spinal Anesthesia for Cesarean Delivery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will compare one technique of fluid administration (combined colloid preload and
      crystalloid colaod) with another one (crystalloid coload) during elective cesarean delivery
      performed under spinal anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This randomized, controlled, double-blind study will be conducted on ASA physical status II
      parturients with full-term singleton pregnancy undergoing elective cesarean delivery under
      spinal anesthesia. Participants will receive either 500 mL colloid preload and 500 mL
      crystalloid coload (Combination group) or 1000 mL crystalloid coload (Coload group). Systolic
      blood pressure will be recorded every minute and ephedrine will be administered when
      hypotension occurs according to a predefined protocol. The total ephedrine dose, time to the
      first ephedrine dose, heart rate, inferior vena cava diameter, nausea/vomiting, and neonatal
      Apgar scores will be recorded.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 20, 2016</start_date>
  <completion_date type="Actual">March 9, 2017</completion_date>
  <primary_completion_date type="Actual">March 9, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total ephedrine dose</measure>
    <time_frame>intraoperative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of hypotension</measure>
    <time_frame>intraoperative</time_frame>
    <description>Hypotension: Systolic blood pressure &lt;80% of baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of severe hypotension</measure>
    <time_frame>intraoperative</time_frame>
    <description>Severe hypotension: Systolic blood pressure &lt;70% of baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to the first ephedrine dose</measure>
    <time_frame>intraoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>intraoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inferior vena cava largest and smallest diameters</measure>
    <time_frame>Baseline, at 1 and 5 minutes after intrathecal injection, delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inferior vena cava collapsibility index</measure>
    <time_frame>Baseline, at 1 and 5 minutes after intrathecal injection, delivery</time_frame>
    <description>Collapsibility index = (Largest diameter - Smallest diameter) / Largest diameter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of nausea and/or vomiting</measure>
    <time_frame>intraoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal Apgar score</measure>
    <time_frame>At 1 and 5 minutes after delivery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Anesthesia, Spinal</condition>
  <condition>Cesarean Section</condition>
  <arm_group>
    <arm_group_label>Combination</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>500 mL colloid preload and 500 mL crystalloid coload. Cesarean delivery performed under spinal anesthesia (intrathecal bupivacaine 12.5 mg and intrathecal fentanyl 15 µg). Ultrasound assessment of the Inferior vena cava diameter. Intravenous ephedrine will be administered.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coload</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1000 mL crystalloid coload. Cesarean delivery performed under spinal anesthesia (intrathecal bupivacaine 12.5 mg and intrathecal fentanyl 15 µg). Ultrasound assessment of the Inferior vena cava diameter. Intravenous ephedrine will be administered.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>500 mL Colloid Preload</intervention_name>
    <description>6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride (voluven®) 500 mL will be rapidly infused before spinal anesthesia</description>
    <arm_group_label>Combination</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Spinal Anesthesia</intervention_name>
    <description>Performed at the L3-L4 or L4-L5 interspace using 27- or 25-gauge spinal needle</description>
    <arm_group_label>Combination</arm_group_label>
    <arm_group_label>Coload</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intrathecal Bupivacaine</intervention_name>
    <description>Bupivacaine 12.5 mg (2.5 mL 0.5%) will be administered in the subarachnoid space</description>
    <arm_group_label>Combination</arm_group_label>
    <arm_group_label>Coload</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intrathecal Fentanyl</intervention_name>
    <description>Fentanyl 15 µg will be administered in the subarachnoid space</description>
    <arm_group_label>Combination</arm_group_label>
    <arm_group_label>Coload</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>500 mL Crystalloid Coload</intervention_name>
    <description>Ringer acetate 500 mL will be rapidly infused immediately after intrathecal injection</description>
    <arm_group_label>Combination</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>1000 mL Crystalloid Coload</intervention_name>
    <description>Ringer acetate 1000 mL will be rapidly infused immediately after intrathecal injection</description>
    <arm_group_label>Coload</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cesarean Delivery</intervention_name>
    <description>Lower segment cesarean section using the Pfannenstiel incision</description>
    <arm_group_label>Combination</arm_group_label>
    <arm_group_label>Coload</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Ultrasound Assessment of the Inferior Vena Cava</intervention_name>
    <description>The inferior vena cava largest and smallest diameters will be measured proximal to the opening of the hepatic veins in the longitudinal axis with the M-mode using a 5-2 MHz curved array ultrasound probe placed longitudinally in the subxiphoid region</description>
    <arm_group_label>Combination</arm_group_label>
    <arm_group_label>Coload</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous Ephedrine</intervention_name>
    <description>Intravenous ephedrine 3, 5, and 10 mg will be administered when Systolic blood pressure decreases below 90%, 80%, and 70% of baseline, respectively.</description>
    <arm_group_label>Combination</arm_group_label>
    <arm_group_label>Coload</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists physical status II parturients

          -  Full term, singleton pregnancy

          -  Elective cesarean delivery under spinal anesthesia

        Exclusion Criteria:

          -  Age &lt;19 or &gt; 40 years

          -  Height &lt;150 cm

          -  Weight &lt;60 kg

          -  Body mass index ≥40 kg/m2

          -  Contraindications to spinal anesthesia (increased intracranial pressure, coagulopathy,
             or local skin infection)

          -  Chronic or pregnancy-induced hypertension

          -  Hemoglobin &lt;10 gm/dL.

          -  Diabetes mellitus, cardiovascular, cerebrovascular, or renal disease

          -  Polyhydramnios or known fetal abnormalities
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed M Tawfik, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mansoura University Hospitals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesia, Mansoura University Hospitals</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahlia</state>
        <zip>35511</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 9, 2016</study_first_submitted>
  <study_first_submitted_qc>November 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2016</study_first_posted>
  <last_update_submitted>March 20, 2017</last_update_submitted>
  <last_update_submitted_qc>March 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Mohamed Mohamed Tawfik</investigator_full_name>
    <investigator_title>Lecturer, Department of anesthesia and surgical intensive care, principal investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Ephedrine</mesh_term>
    <mesh_term>Pseudoephedrine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

